The effect of secukinumab on patient-reported outcomes in patients with active psoriatic arthritis in a randomised phase 3 trial by Strand, V, Kaeley, GS, Bergman, MJ, Gladman, DD, Coates, LC, Sherif, B, Hur, P, Parikh, B, Gilloteau, I, Mease, PJ

Management of dactylitis in patients with psoriatic arthritis: an updated literature review informing the 2021 GRAPPA treatment recommendations by Palominos, PE, Fernández-Ávila, DG, Coates, LC, Adebajo, A, Toukap, AN, Abogamal, A, Polachek, A, van Kuijk, AWR, Caso, F, de Marco, G, Kaeley, GS, Steinkoenig, I, Chau, J, Feletar, M, Vis, M, Elkayam, O, Sewerin, P, d'Angelo, S, Aydin, SZ, AlShehhi, W, Helliwell, PS